Avalo Therapeutics, Inc. AVTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-11-13
Avalo Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 916,142 | $13.7M |
| MILLENNIUM MANAGEMENT LLC | 835,484 | $12.5M |
| CITADEL ADVISORS LLC | 260,535 | $3.9M |
| RENAISSANCE TECHNOLOGIES LLC | 120,114 | $1.8M |
| TWO SIGMA INVESTMENTS, LP | 64,425 | $961,865 |
| BlackRock Finance, Inc. | 329 | $4,103 |
Source: SEC EDGAR filings · CIK 0001534120 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.